Jan 18 (Reuters) - Elicera Therapeutics AB ELIC.ST :
* ELICERA'S BOARD OF DIRECTORS PROPOSES A RIGHTS ISSUE OF
UNITS OF
APPROXIMATELY SEK 64 MILLION
* RIGHTS ISSUE IS COVERED TO APPROXIMATELY 43 PERCENT
THROUGH
SUBSCRIPTION COMMITMENTS AND UNDERWRITING COMMITMENTS
* SUBSCRIPTION PRICE PER UNIT IS SEK 16.20, CORRESPONDING TO
SEK
1.80 PER SHARE
* SUBSCRIPTION PERIOD FOR RIGHTS ISSUE WILL RUN FROM
FEBRUARY 23,
2024, TO MARCH 8, 2024
* RIGHTS ISSUE TO FUND CLINICAL PHASE I/IIA STUDY FOR
ELICERA'S
DRUG CANDIDATE ELC-301
Source text for Eikon: ID:nWkr5QhwMM
Further company coverage: ELIC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))